NCT00358462View on ClinicalTrials.gov

Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA)

PHASE3CompletedINTERVENTIONAL
Enrollment

606

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Urethritis
Interventions
DRUG

Azithromycin

two 500mg tablets or four 250mg tablets administered as a single dose

DRUG

Doxycycline

one 100mg capsule administered twice daily for seven days

Trial Locations (1)

98104

Public Health -- Seattle & King County Sexually Transmitted Diseases Clinic located at Harborview Medical Center, Seattle

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Washington

OTHER

NCT00358462 - Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA) | Biotech Hunter | Biotech Hunter